As of 14 Oct 2026, OTR Therapeutics has raised $100M across 1 verified round on record; latest: $100 million Series A, announced 5 Dec 2025.
OTR Therapeutics focuses on discovering and acquiring preclinical assets to develop innovative therapies for patients.
otr-tx.comShanghai, ChinaBiotech
1 source
The release announces the round on December 5, 2025, while stating that the financing closed in June 2025. No lead investor or valuation is stated.
Published by hand (otr-tx.com): "OTR Therapeutics, a biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, emerged from stealth and announced today the successful completion of a $100 million Series A financing closed in June 2025.": biggest-rounds completeness (K): the row's own page states the round
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-12-05 | not stated | No recent discussion |
1 source [ VERIFIED · CORRECTED ] read against 1 source The release announces the round on December 5, 2025, while stating that the financing closed in June 2025. No lead investor or valuation is stated. Published by hand (otr-tx.com): "OTR Therapeutics, a biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, emerged from stealth and announced today the successful completion of a $100 million Series A financing closed in June 2025.": biggest-rounds completeness (K): the row's own page states the round | ||||